Berwin Brent, Hart Justin P, Pizzo Salvatore V, Nicchitta Christopher V
Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
J Immunol. 2002 May 1;168(9):4282-6. doi: 10.4049/jimmunol.168.9.4282.
GRP94(gp96) elicits CD8(+) T cell responses against its bound peptides, a process requiring access of its associated peptides into the MHC class I cross-presentation pathway of APCs. Entry into this pathway requires receptor-mediated endocytosis, and CD91 (low-density lipoprotein receptor-related protein) has been reported to be the receptor mediating GRP94 uptake into APC. However, a direct role for CD91 in chaperone-based peptide Ag re-presentation has not been demonstrated. We investigated the contribution of CD91 to GRP94 cell surface binding, internalization, and trafficking in APCs. Whereas a clear role for CD91 in alpha(2)-macroglobulin binding and uptake was readily obtained, the addition of excess CD91 ligand, activated alpha(2)-macroglobulin, or receptor-associated protein, an antagonist of all known CD91 ligands, did not affect GRP94 cell surface binding, receptor-mediated endocytosis, or peptide re-presentation. These data identify a CD91-independent, GRP94 internalization pathway that functions in peptide Ag re-presentation.
GRP94(gp96)可引发针对其结合肽的CD8(+)T细胞反应,这一过程要求其相关肽进入抗原呈递细胞(APC)的MHC I类交叉呈递途径。进入该途径需要受体介导的内吞作用,据报道,CD91(低密度脂蛋白受体相关蛋白)是介导GRP94被APC摄取的受体。然而,CD91在基于伴侣蛋白的肽抗原再呈递中的直接作用尚未得到证实。我们研究了CD91对GRP94在APC细胞表面结合、内化和运输的作用。虽然很容易观察到CD91在α2-巨球蛋白结合和摄取中的明确作用,但添加过量的CD91配体、活化的α2-巨球蛋白或受体相关蛋白(一种所有已知CD91配体的拮抗剂)并不影响GRP94的细胞表面结合、受体介导的内吞作用或肽的再呈递。这些数据确定了一种不依赖CD91的GRP94内化途径,该途径在肽抗原再呈递中发挥作用。